Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 803 results for "sandoz inc"

A riddle wrapped in a mystery inside an enigma: the Federal Ci...

, the Federal Circuit issued a divided decision in Amgen Inc. v. Sandoz Inc. , No. 15-1499 (Fed. Cir. July 21, 2015), interpreting two provisions of the Biologics Price Competition and Innovation Act (BPCIA).The Federal Circuit decided two issues: ... Lexology, 1 month ago
Federal Circuit Delays Sandoz Biosimilar until Sept. 2 AAPS Pharmceutica, 1 month ago

5 images for sandoz inc

White & Case, 3 weeks ago
Pharmacy Times, 1 month ago
PR inside, 1 month ago
Bidness Etc, 3 weeks ago
PRWeb UK, 1 month ago

Sandoz introduces generic version of asthma drug in US

Sandoz Inc. has introduced budesonide inhalation suspension, a generic version of Pulmicort Respules, or budesonide, inhalation suspension 1mg strength, indicated for the treatment of asthma, in the US. Sandoz's budesonide inhalation suspension ...
 Individual.com3 weeks ago

Sandoz receives Appeals court ruling for Zarxio in US

Sandoz Inc. has received favorable ruling from the US Court of Appeals for the Federal Circuit for Zarxio, a biosimilar product. The US Court of Appeals for the Federal Circuit's ruling paves the way for Sandoz to launch Zarxio after September 2, as ...
 Individual.com1 month ago Court of Appeal Ruling Opens Door for Sandoz's Neupogen Copy  PharmExec.com1 month ago

The Medicines Company Authorizes Generic Launch of Angiomax

— TheMedicines Companyannounced an agreement July 9 with Sandoz Inc. for the distribution of an authorized generic of Angiomax (bivalirudin) for injection in the United States. Angiomax is indicated in patients undergoing percutaneous coronary ...
 Diagnostic & Invasive Cardiology1 month ago Sandoz to distribute Medicines Company's anticoagulant in US  Individual.com1 month ago

Sandoz Inc recalls India-made anti-allergic tablets in US

NEW DELHI: Drug firm Sandoz Inc is recalling India-made 1,023,430 units of anti-allergic Cetirizine HCl chewable tablets in the US due to impurity concerns. According to information on the USFDA site, the recall is for Cetirizine HCl chewable tablets of 10 ...
 Economic Times2 months ago

Novartis, Tory Burch, Ashley Madison Hack: Intellectual Property

Novartis AG's Sandoz unit may begin selling the first copy of Amgen Inc.'s cancer treatment Neupogen as soon as Sept. 2 after an appeals court ruling Tuesday rejected arguments that it failed to follow regulatory rules. Sandoz didn't violate the ...
 Boe Report1 month ago Novartis May Sell Copy of Amgen's Neupogen Drug in September  La Repubblica1 month ago

Biosimilars & Biobetters USA: Hear from Sandoz, MedImmune, Selecta Biosciences, Bristows LLP, BioInsight Inc

PRWeb SMi's conference on Biosimilars & Biobetters USA 2015 will be taking place in Renaissance Woodbridge Hotel in Iselin, New Jersey, USA, on the 16th and 17th of November 2015. The 2-day event programme will offer effective strategies and ...
 Wall Street Business Network1 month ago

Insite Vision Inc. v. Sandoz, Inc.

Case Name: , 783 F.3d 853 (Fed. Cir. Apr. 9, 2015) (Circuit Judges Prost, Newman, and Linn presiding; Opinion by Linn, J.) (Appeal from D.N.J., Cooper, J.) Drug Product and Patent(s)-in-Suit: Azasite ® (azithromycin); U.S. Patents Nos.
 JD Supra1 month ago Shire Development, LLC v. Watson Pharms., Inc.  JD Supra1 month ago Teva Pharms. USA, Inc., v. Sandoz, Inc.  JD Supra1 month ago

Novartis AG (NVS)'s Sandoz Shuttered Three Plants, Lays Off 720 7/24/2015

July 24, 2015 By Mark Terry , Breaking News Staff Sandoz, Inc. , the generic pharmaceuticals division of Swiss-based Novartis AG ( NVS ), announced yesterday that it will close three manufacturing facilities, two in Germany and ...
 ClinicSpace1 month ago Novartis AG???s Sandoz Shuttered Three Plants, Lays Off 720  BioSpace1 month ago
Bidness Etc

AbbVie Inc And Amgen, Inc. Threatened By Biosimilars

AbbVie Inc. ( NYSE:ABBV ), Amgen Inc. ( NASDAQ:AMGN ), and Johnson & Johnson ( NYSE:JNJ ) are among the drug-makers who are most exposed to the risk of sales decline for their top revenue-generating drugs, amid the impending launch of biosimilar ...
 Bidness Etc2 weeks ago Cancer Immunotherapy - Pfizer Inc., Bristol-Myers Squibb Co Research New Approach  Bidness Etc3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less